Physician

Jeffrey G Mace, MD

According to 2025 Medicare claims, Jeffrey Mace, MD (NPI: 1861484511) practices cardiology in the Santa Cruz-Watsonville, CA market, with the plurality of this provider's patient population coming from Santa Cruz, CA. This provider's primary affiliated billing organization is JEFFREY G. MACE, M.D., PROFESSIONAL CORPORATION (NPI: 1235269374; TIN: 942618460) and primary practice location at 95076-0334.

Mace's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 119 traditional Medicare patients, billed 6,595 HCPCS/CPT codes, and received $751,469 in Medicare payments. The top billing code was 93351 (Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report). Part D data shows 2,940 prescription claims across 113 beneficiaries totaling $225,626 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 56 claims. Open Payments data shows 1 records totaling $104. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,874 and ending at $17,330.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	234	8,795	$772,679
2016	225	10,578	$918,053
2017	212	10,788	$906,892
2018	199	10,657	$933,779
2019	188	10,589	$971,040
2020	169	9,070	$814,031
2021	148	6,915	$760,350
2022	138	6,374	$680,441
2023	130	7,419	$787,714
2024	119	6,595	$751,469

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	181	4,264	$239,361
2016	178	4,207	$237,235
2017	166	3,952	$220,148
2018	153	3,978	$239,014
2019	153	3,689	$219,533
2020	138	3,325	$172,334
2021	133	3,046	$198,174
2022	124	2,926	$211,865
2023	122	3,267	$264,427
2024	113	2,940	$225,626

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	25	105	$6,996
2016	15	71	$657
2017	14	75	$4,007
2018	14	55	$536
2019	15	52	$544
2020	13	75	$2,693
2021	17	108	$2,700
2022	18	70	$609
2023	14	73	$1,897
2024	N/R	56	$12,564

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93351	Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report	53	69	$193
93930	Ultrasound of arm arteries or artery grafts	59	90	$167
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	87	137	$156
93880	Ultrasound of both sides of head and neck blood flow	69	93	$153
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	119	3,197	$144

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	53	1,806	$40,177
Jardiance	Empagliflozin	32	1,740	$33,244
Gabapentin	Gabapentin	158	7,828	$3,340
Enoxaparin Sodium	Enoxaparin Sodium	12	201	$2,854
Tamsulosin Hcl	Tamsulosin Hcl	111	7,930	$2,814

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$10,227
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	23	$2,056
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	21	$281

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$104	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey G. Mace, MD?

Tedicare shows public-source Medicare data for Jeffrey G. Mace, MD (NPI 1861484511), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey G. Mace, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey G. Mace, MD?

Jeffrey G. Mace, MD is linked to JEFFREY G. MACE, M.D., PROFESSIONAL CORPORATION (billing NPI 1235269374) in the available physician profile data.

Does Jeffrey G. Mace, MD have Open Payments data?

Jeffrey G. Mace, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.